Epigene Labs announced multi-year collaboration with Servier on AI for precision oncology R&D. Read more
Realize the full potential of your precision cancer research and drug development by tapping into a mine of diverse oncology data. Maximize opportunities to gain a smarter, data-driven edge to your programs.
Using artificial intelligence and next-generation bioinformatics, the mCUBE platform assembles comprehensive and up-to-date information from multiple databases into a single, unified resource. By providing you with a high-resolution and multi-dimensional view of disease biology, it directly supports drug discovery and development in precision oncology.
Benefit from rich, harmonized, and integrated data tailored for your R&D programs.
Derived from 100,000 patient sample profiles across 1000 datasets
Spanning multiple layers of genomic information
Covers over 30 cancer types
Identify and validate novel targets for antigen-targeting modalities.
Gain insights into disease biology, pinpoint patient populations, and define optimal indications.
